Copyright © 2022 Binhui Bio All Rights ReservedE.ICP B. No.16007335
Doses Escalation (Phase I)
Doses Extension (Phase II)
Intra he patic cholangiocarcinoma
The clinical trials of oncolytic type II herpes simplex virus OH2 injection (BS001) monotherapy/combination therapy have been conducted in 20+ research centers (hospitals) in China, Nearly 300 subjects were enrolled for various indications.